YAO, F.; SHI, Z. MiR-16 is promising to be a therapy target to alleviate atherosclerosis. Diagnostics and Therapeutics, [S. l.], v. 2, n. 1, p. 13–15, 2023. DOI: 10.55976/dt.22023116113-15. Disponível em: https://ojs.luminescience.cn/DT/article/view/161. Acesso em: 25 dec. 2024.